1. Home
  2. PCYO vs TNXP Comparison

PCYO vs TNXP Comparison

Compare PCYO & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pure Cycle Corporation

PCYO

Pure Cycle Corporation

HOLD

Current Price

$11.50

Market Cap

249.5M

Sector

Utilities

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

N/A

Current Price

$12.70

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PCYO
TNXP
Founded
1976
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
249.5M
199.7M
IPO Year
1995
2008

Fundamental Metrics

Financial Performance
Metric
PCYO
TNXP
Price
$11.50
$12.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
68.5K
448.1K
Earning Date
04-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
12.50
91.75
EPS
0.36
N/A
Revenue
$1,227,787.00
$13,107,000.00
Revenue This Year
N/A
$558.11
Revenue Next Year
N/A
$38.29
P/E Ratio
$31.78
N/A
Revenue Growth
171.54
29.85
52 Week Low
$9.71
$9.40
52 Week High
$12.44
$39.45

Technical Indicators

Market Signals
Indicator
PCYO
TNXP
Relative Strength Index (RSI) 66.57 59.67
Support Level $10.51 $11.98
Resistance Level $11.58 $13.36
Average True Range (ATR) 0.30 0.85
MACD 0.07 0.21
Stochastic Oscillator 92.02 72.75

Price Performance

Historical Comparison
PCYO
TNXP

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: